NAS Calls for Single Federal Agency to Oversee 'Unorganized' Biomarker Field | GenomeWeb
NEW YORK (GenomeWeb News) — Biomarkers may help fight a variety of cancers, but that potential is being undermined by confusing regulations and standards, and “piecemeal and unorganized efforts,” according to a report issued today by the National Academies of Science’s Institute of Medicine.
The Institute proposed a set of suggestions that it said would spur research and development advances in the field, which would include unifying oversight of the field under a single entity.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.